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ABSTRACT

Sixty male albino rats received DDAVP, a placebo, or control
treatment and were tested on a brightness discrimination task.

Three

groups (DDAVP, placebo, and control) were tested in the morning and
three groups were tested in the evening for possible diurnal influences
of DDAVP.

The acquisition and reversal of the brightness discrimina

tion, along with the retention of the reversal problem after a fiveday retention interval were analyzed.

Inspection of forward and

backward learning curves plotted for each task revealed facilitated
acquisition along with an initial impairment of reversal learning in
those animals treated with DDAVP.

These results were consistent with

previous theoretical interpretations of other vasopressin analogues,
such as DDAVP, and their effects upon the behavior of animals.

These

results supported a memorial interpretation of DDAVP's effects upon
behavior.

This was short-term in duration, as no retention effects

were obtained.

It was also found that DDAVP's effects were not

influenced by diurnal processes.

viii

CHAPTER 1

INTRODUCTION

During the past two decades a number of researchers (i.e., DeWied
& Bohus 1966; DeWied 1969; 1974; Kastin, Sandman, Stratton, Schally, &
Miller 1975) have explored the possibility that several pituitary
hormones may have behavioral effects in addition to their classically
documented endocrine effects.

Hormones are chemical transmitters

which are normally produced by specialized cells, carried by the
blood stream, and received by specialized receptor cells located on
target tissues at a distance from where they are synthesized (Martin,
Reichlin, & Brown 1977).

Not only does the central nervous system

(CNS) control most glandular secretions, whether internal (endocrine)
or external (exocrine), but evidence has accumulated indicating that
hormones, in turn, effect the CNS (DeWied & Bohus 1979).

A number of

pituitary and hypothalamic hormones are known to be peptides (i.e.,
adrenocotropic hormone (ACTH) and the related melanocyte-stimulating
hormones a-MSH and g-MSH). ACTH and MSH derived peptides have been
demonstrated to affect motivational, memorial, and learning processes
in the rat (DeWied 1974) and motivation and attention in humans
(Kastin et al. 1975).

Recently a great deal of research has been

stimulated by another peptide hormone, vasopressin, and its possible
role as a behavioral mediator.
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Vasopressin has been shown to produce a long-term increased
resistance to extinction of avoidance responding in intact rats
(DeWied & Bohus 1966; DeWied 1971a).

A variety of avoidance tasks

have been used to demonstrate this effect, such as conditioned
avoidance in shuttle-box and pole-jumping paradigms (DeWied 1969;
1971a; 1971b).

Vasopressin has also been found to influence

appetitively motivated behavior.

Although in one study vasopressin

was found not to effect a food-running approach response (Garrud,
Gray, & DeWied 1974) subsequent studies indicated that vasopressin
delayed extinction of responding in a T-maze when either sex (Bohus
1977), or food (Hostetter, Jubb, & Kozlowski 1977) was used as a
reinforcer.
The results obtained in studies of avoidance conditioning have
been interpreted as indicating that vasopressin exerts its effects
upon memorial processes (Van Wimersma Greidanus, Bohus, & DeWied
1975; DeWied & Gispen 1977; DeWied & Bohus 1979).

However, research

involving behaviorally active pituitary hormones other than vasopres
sin, has suggested that these peptides affect attention (Sandman,
Miller, Kastin, & Schally 1972; Beckwith, Sandman & Kastin 1976).

No

one has yet addressed the question of whether vasopressin may also
influence attention.

Sandman et al. (1972) were the first to utilize

a discrimination task to investigate separate attentional and memorial
effects of peptide hormones.

Because the discrimination task has

been used in previous neuroendocrine research and because it provides
a means for differentiating between memory and attention, this task
was chosen for the present study.

Thus, the first purpose of this
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investigation was to explore the effects of vasopressin on an
appetitively motivated discrimination task.
Studies involving vasopressin have utilized a number of different
vasopressin analogues.

Behavioral effects have been obtained using

pitressin (DeWied & Bohus 1966), desglycinamide lysine vasopressin
(DG-LVP) (Wang 1972) , lysine vasopressin (LVP) (Bohus 1977), and
other similar analogues.

Desmopressin acetate (DDAVP) is a recently

developed vasopressin analogue (Kosman 1978) which has been found to
be as effective as other vasopressin analogues in eliminating the
effects of puromycin-induced amnesia in mice (Walter, Hoffman,
Flexner, & Flexner 1975).

To date, no attempt has been made to

investigate the possibility of behavioral effects when DDAVP is
administered intranasally to rats.

Therefore, a second purpose of

this study was to explore the effects of DDAVP on a brightness
discrimination task.
Finally, recent attention has been called to the importance of
studying light-dark cycles when investigating the effects of peptide
hormones (Beckwith & Sandman 1978).

Diurnal effects have been noted

to interact with the effects of ACTH and MSH (Sandman, Kastin, &
Schally 1971; Pagano & Lovely 1972).

Thus, the third purpose of this

study was to investigate possible diurnal effects of vasopressin.

CHAPTER II

LITERATURE REVIEW

Synthesis and Actions of Vasopressin
Vasopressin is synthesized in the supraoptic and paraventricular
nuclei of the hypothalamus (Brown & Barker 1966).

It is then trans

ported along the supraoptic-hypophysial and paraventricular-hypophysial
nerve tracts down through the infundibulum and neural stalk to the
posterior lobe of the pituitary.

The posterior pituitary (neural

lobe or neurohypophysis) is chiefly an area of storage and release
of the posterior pituitary hormones (vasopressin and oxytocin).
Two natural forms of vasopressin have been identified in
mammals:

Arginine vasopressin (AVP), the most commonly occurring

form; and Lysine vasopressin (LVP), identified alone only in the
posterior pituitary of the pig (Turner & Bagnara 1976).

Currently,

there are a number of synthesized forms of vasopressin.

One is

pitressin, which is a water-insoluble compound of posterior pituitary
extract and tannic acid.

Pitressin is "long-acting" as a result of

its being an oil based solution.

Another is desglycinamide lysine

vasopressin (DG-LVP), a pure vasopressin analogue which is practically
devoid of endocrine effects but has been found to produce the same
behavioral actions as do other vasopressin analogues with full
endocrine effects (Wang 1972).

Finally, another common vasopressin

analogue is desmopressin acetate (DDAVP) (Kosman 1978).

4

This form is
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clinically popular because of its route of administration (intranasal)
and its longer half-life (about 76 minutes versus 14.5 minutes for
LVP), which extends its antidiuretic effects from 8 hours to 20 hours.
Vasopressin (also referred to as antidiuretic hormone or ADH) is
a hormone which is released from the posterior lobe of the pituitary.
Although the name implies that ADH is a vasopressor agent, removal
of the posterior pituitary produces no significant decrease in blood
pressure and exogenous administration of vasopressin has only minor
effects as compared to other pressor agents (Brown & Barker 1966).
Indeed in humans, the only responses to injection of vasopressin are
pallor and decreased heart rate (Brown & Barker 1966).

To date,

vasopressin is not considered to have any clinical importance as a
pressor agent.

The principle physiological function of vasopressin

appears to be induction of fluid retention by the kidney (hence,
"antidiuretic hormone") (Turner & Bagnara 1976).

As an antidiuretic

agent, vasopressin acts to prevent excessive fluid loss by stimulating
the reabsorption of fluids by the kidneys which results in the
excretion of concentrated urine (Turner & Bagnara 1976).

Hypophysectomy Studies
Vasopressin is released in response to a number of factors,
including systemic stress (i.e., hypovolemia or decreased blood
pressure), pharmacological agents (i.e., nicotine, alcohol, or mor
phine), and emotional stress (i.e., anxiety or pain) (Martin et al.
1977).

In addition to inducing the release of vasopressin, stress

also results in the release of ACTH from the adenohypophysis, anterior
portion of the pituitary (Martin et al. 1977).

This association
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between vasopressin and ACTH led Mirsky, Stein, and Paulish (1954)
and others to hypothesize that vasopressin may be responsible for the
release of ACTH.

Subsequent work by DeWied (1961) and Smelik,

Gaarenstroom, Konojnendijk, and DeWied (1962) indicated that removal
of the posterior lobe of the pituitary did result in the disruption
of ACTH release in response to emotional stress but did not interfere
with ACTH release in response to systemic stress.
Posterior lobectomized rats subjected to emotional stress such
as transfer to a strange environment, sound, or pain, show less
of an adrenocortical response to these stresses than shamoperated control animals. Posterior lobectomy, however, did
not affect the release of ACTH in response to systemic stress
like hemorrhage under ether anaethesia or the injection of
histamine or nicotine (DeWied 1971b, p. 391).
DeWied (1961) showed that treatment with pitressin resulted in a
nearly complete return of this pituitary-adrenal response to emotional
stress.
These results suggest that the absence of posterior pituitary
principles had caused the defect in the release mechanism of
ACTH following neurogenic stress. However, we felt that it
might also be possible that the deficient pituitary-adrenal
response to neurogenic stimulation resulted from a defective
translation of environmental stimuli to the pituitary of
posterior lobectomized rats. If this were true the origin of
the reduced pituitary response to neurogenic stress might be
located in higher structures. In other words, posterior
lobectomy might result in alterations in behavior (DeWied
1971b, pp. 391-392).
This led to a number of studies investigating the behavior of
posterior lobectomized rats.

In 1965, DeWied investigated the behavior

of such animals using a pole-jumping type conditioned avoidance
response (CAR).

Acquisition of the CAR in these rats did not differ

significantly from that of sham-operated controls, however extinction
of their CAR was significantly faster.

This suggested to DeWied that

posterior lobectomized rats were unable to maintain the CAR in the
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absence of punishment.

Furthermore, treatment with pitressin, during

either acquisition or extinction, restored the extinction behavior to
normal.

Thus, when pitressin was administered to the posterior

lobectomized rats, they were able to maintain the CAR in the absence
of punishment.

This result has been replicated in other studies using

conditioned avoidance paradigms to test the actions of more purified
vasopressin analogues such as LVP (Bohus, Gispen, & DeWied 1973;
DeWied 1965; 1967).

One possible explanation for this result is that

loss of the peptide produces motor and/or sensory deficits.

However,

escape behavior in a runway was not affected by the removal of the
posterior lobe of the pituitary (DeWied 1969) which suggests that
motor and/or sensory failures are not responsible for the behavioral
disturbance noted during extinction in posterior lobectomized rats.
Pitressin is an extract of posterior and intermediate lobe tissue
and contains various hormones such as ACTH, thyroid-stimulating
hormone (TSH), vasopressin, and oxytocin (DeWied 1971b).

Therefore

the above results could be due to the actions of any one, or any
combination of the substances contained in pitressin.

As indicated

above, a purified form of vasopressin, LVP, had the same effect as
pitressin.

Moreover, ACTH and MSH have also been shown to slow the

rate of extinction of an avoidance response (DeWied 1966).

Treatment

with long-lasting ACTH during the acquisition period had little effect
on performance during extinction, whereas, ACTH administered during
the extinction period was effective in restoring responding.
Posterior lobectomized rats treated with pitressin either during the
acquisition period or the extinction period, resulted in the restora
tion of the extinction behavior (DeWied 1969).

Thus, when ACTH was
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isolated from the pitressin compound, identical results were not
obtained.

Pitressin preserved the CAR irrespective of the time of

treatment and resulted in "long-term" behavioral effects.
The influence of total hypophysectomy (removal of both adeno- and
neurohypophysis) on passive avoidance behavior has also been studied
(Lissak & Bohus 1972).

Hypophysectomized and sham-operated rats

received unavoidable shock when they entered a dark compartment and
were then tested 24, 48, and 240 hours later for retention.

Results

indicated that hypophysectomy led to the supression of the passive
avoidance response, i.e., the hypophysectomized rats spent signifi
cantly more time in the dark compartment than controls at both the 24
and 48 hour intervals.

These are interesting results since

hypophysectomized rats have been found to be more sensitive to
electric shock than sham-operated controls (Gispen, Van Wimersma
Greidanus, & DeWied 1970) and thus one would expect the single trial
of unavoidable shock to produce an even stronger avoidance response
in these animals.

Since the results obtained by Lissak and Bohus

(1972) were in fact opposite those one would predict from the Gispen
et al. (1970) study, a learning or memory deficit may be suggested.
Acquisition was unaffected in the hypophysectomized animals, yet
extinction was facilitated, thus memory has been proposed as the
disrupted process rather than learning (Lissak & Bohus 1972).
In summary, studies involving either partial or total hypophysec
tomy have focused on investigating shock motivated avoidance behavior
in rats.

Results from these studies indicated that hypophysectomized

animals were able to acquire the avoidance response but that extinction
was significantly facilitated.

Administration of pitressin, LVP, or
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ACTH was found to restore the extinction behavior to normal, however
these results were obtained irrespective of time of administration of
the pitressin or LVP, which was not the case with ACTH.

Thus, the

vasopressin and ACTH peptides did not yield the same results, with
the effects of vasopressin being much longer in duration, or perhaps
these peptides were effective at different phases of the learning
process (Sandman, Beckwith, & Kastin 1980).

Also, it was determined

that the behavioral disturbance noted during extinction was not due
to motor and/or sensory deficits in the hypophysectomized animals.
From this line of investigation, it has been proposed that memorial
processes are disrupted in response to the lack of vasopressin in
the hypophysectomized animals (Lissak & Bohus 1972).

Brattleboro Strain Investigations
The hypophysectomized rat is not only deficient in vasopressin,
but also several other peptides, e.g. ACTH, MSH, and TSH.

Furthermore,

the posterior-lobectomized rat, although deficient in posterior
pituitary principles, still manufactures vasopressin in the hypo
thalamus.

Therefore, a superior model to investigate the role of

vasopressin in learning and/or memory is the Brattleboro strain of
rat.

The Brattleboro strain possesses a recessive gene which is

expressed as diabetes insipidus (DI) in homozygous (HO) offspring
(Valtin & Schroeder 1964; Valtin 1967) who have an absolute inability
to synthesize vasopressin (Valtin, Sawyer, & Sokol 1965).

Vasopressin

has been shown to be absent in the neurohypophysis, blood, and urine
of homozygous-diabetes insipidus (HO-DI) rats (Mohring & Mohring
1975; Miller & Moses 1971).

Rats heterozygous for DI (HE-DI) have
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partial vasopressin deficiency, however, their water metabolism is
relatively normal.

Both HO-DI and HE-DI rats can synthesize oxytocin

(Valtin et al. 1965).

Thus, Brattleboro strain rats provide a source

for studying behavioral effects of vasopressin deficiency without the
confounding that occurs with the surgical intervention techniques
used in studies of the effects of hypophysectomy.
Bohus, Van Wimersma Greidanus, and DeWied (1975) performed several
studies comparing HO-DI rats with HE-DI and normal Wistar strain rats.
Their results indicated that acquisition of an active avoidance
(shuttle-box) response was inferior in the HO-DI rats as compared to
both HE-DI and normal rats.

In addition, HO-DI animals demonstrated

a faster extinction rate than HE-DI or normal rats.

The HE-DI

animals showed a faster rate of extinction than did normal strain
rats, however the HO-DI rats were considerably faster than HE-DI or
normals in their rate of extinction.

There were no significant

differences in acquisition rates on an active pole-jumping avoidance
response between HO-DI and HE-DI rats, however, normals were found
to be significantly faster in acquiring the avoidance response.

Both

HO-DI and HE-DI animals demonstrated a faster rate of extinction of
the pole-jumping response than normals, with HO-DI extinction rates
being the fastest.

These results indicate that during an active

avoidance response task, not only is the maintenance of a CAR impaired
in vasopressin deficient animals but also acquisition of such a
response is impaired.
The passive avoidance behavior of HO-DI rats has been investi
gated by Bohus et al. (1975).

HO-DI animals demonstrated a full

passive avoidance response at 3 hours but no passive avoidance response
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was noted 24 hours after the learning trial.

On the other hand, HE-DI

and normal animals displayed full passive avoidance responses at each
of the intervals.

The authors therefore concluded that the lack of

vasopressin in HO-DI animals resulted in a memory deficit, e.g.
retention of the passive avoidance response or extinction of the
response was affected by the absence of vasopressin.

However,

Celestian, Carey, and Miller (1975), using a shuttle-box avoidance
response, obtained results that indicated that HO-DI animals also
demonstrated acquisition difficulties, with only 30% reaching
criterion on the avoidance task.

Contrary to the findings of Bohus

et al. (1975), HO-DI rats in this study demonstrated slower extinction
rates as compared to HE-DI and normal animals.

Perhaps different

paradigms within which these animals are tested yield different
results, however, Celestain et al. (1975) suggested that their results
favored a learning hypothesis in regards to analyzing the effects of
vasopressin deficiency on behavior.

Since the majority (70%) of

the HO-DI animals were unable to acquire the avoidance response,
perhaps learning processes were disrupted by the vasopressin
deficiency present in the HO-DI animals.

Miller, Barranoa, Dean,

and Brush (1976) attempted to resolve these conflicting findings.
Using conditions and parameters virtually identical to those used by
Bohus et al. (1975) (passive avoidance) their results indicated that
avoidance behavior and acquisition were both impaired in the HO-DI
and HE-DI animals, but most notably in the HO-DI rats.

They also

found resistance to extinction to be greater in HO-DI rats as compared
to the HE-DI's.

However, when they increased the shock level used,

HO-DI rats did show faster extinction and inferior acquisition of the
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avoidance response relative to the HE-DI and normal rats.

These

results indicate that this area of research seems to be extremely
sensitive to changes in procedure and parameters, thus one must be
careful in drawing conclusions from one line of investigation.
Beckwith and Sandman (1978) pointed out that few studies have explored
the relationship of shock intensity and neuropeptide effects, even
though shock has been used pervasively in this area of study and
despite existing evidence that a shock intensity-peptide interaction
exists (Beatty, Beatty, Bowman, & Gilchrist 1970; Stratton & Kastin
1974).
Using a step-through passive avoidance paradigm, DeWied, Bohus,
and Van Wimersma Greidanus (1975) found an absence of passive avoidance
behavior in HO-DI rats 24 hours after the learning trial.

Further

more, administration of AVP or DG-LVP resulted in the restoration of
passive avoidance abilities.

Avoidance latencies of HO-DI rats

treated with these vasopressin analogues did not differ significantly
from those of the HE-DI or normal rats.

Since DG-LVP is practically

devoid of antidiuretic effects, restoration of passive avoidance
responding was not related to metabolic normalization.

HO-DI rats

were found to exhibit normal passive avoidance behavior if tested
immediately or one hour after the learning trial, but no passive
avoidance behavior was noted 24 hours after the learning trial.

Since

acquisition of the passive avoidance appeared to be unimpaired, yet
retention of the passive avoidance response was impaired, this again
suggests that memory processes rather than learning processes are
disrupted in the absence of vasopressin.
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Thus far, studies utilizing the Brattleboro strain of rat as a
source from which to study the effects of vasopressin deficiency on
behavior, have yielded conflicting results.

Generally, however, it

appears that vasopressin deficiency present in HO-DI animals results
in disrupted acquisition and extinction behavior, with the exact
nature of the disruption being sensitive to experimental parameters
such as shock intensity.

In addition, results indicated that vasopres

sin administration restored passive avoidance behavior in HO-DI
animals.

A general conclusion could be thus drawn, that vasopressin

deficiency, as noted in both hypophysectomized and HO-DI animals,
results in disrupted avoidance behavior and is restored by vasopressin
administration.

Effects of Vasopressin
on Intact Animals
Numerous investigations have demonstrated the effects of vasopres
sin on the behavior of intact rats.

DeWied and Bohus (1966) studied

the effects of pitressin administration on a shuttle-box CAR.
Pitressin was administered either during acquisition or immediately
prior to the first extinction session.

They obtained no effects upon

the acquisition of the CAR, however, the retention of the CAR was
greatly enhanced.

The inhibition of extinction was obtained regard

less of the time of pitressin administration.

The CAR was retained

for a significantly longer period of time in animals receiving
pitressin as compared to control animals.

These results were inter

preted by the authors as indicating that vasopressin exerts an effect
upon "long-term" memory functions.

Similar results have been obtained

using different avoidance tasks and different vasopressin analogues.
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Increased resistance to extinction was demonstrated with AVP adminis
tration (DeWied 1976) or LVP administration (DeWied 1970; Ader &
DeWied 1972).

Further, DeWied (1970) obtained results indicating that

there is an optimum time interval within which vasopressin's effects
may be obtained.

To be completely effective in inhibiting extinction,

LVP must be administered during the period beginning immediately prior
to acquisition and ending one hour after the first extinction session
(24 hours post-acquisition).

Administration six hours following the

first extinction session was not effective in inhibiting the extinc
tion of the active avoidance response.

This evidence was taken as

support for the suggestion that vasopressin affects memory
consolidation.
Passive avoidance paradigms have also been used extensively to
study the effects of vasopressin on the behavior of intact rats.
Kovas, Vecsei, and Telegdy (1978) found that animals treated with
vasopressin demonstrated an increased resistance to extinction of a
passive avoidance response.

Ader and DeWied (1972) reported that LVP

administration increased resistance to extinction of a passive avoid
ance response irrespective of the time of treatment.

Increased

resistance to extinction was demonstrated whether LVP was administered
immediately after the acquisition trial or immediately prior to the
first extinction session (24 hours post-acquisition).

Initially these

results may appear to conflict with those obtained by DeWied (1970).
However, Ader and DeWied (1972) did not test for possible effects of
a six-hour-post-extinction administration of LVP as did DeWied (1970),
thus, the possibility remains that there is an optimum vasopressin
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administration period for passive avoidance behavior to be affected
similar to that reported by DeWied (1970) with active avoidance.
At this point it is also important to point out that pitressin is
a long-acting compound which, in humans, can remain active up to 96
hours after administration (Physicians Desk Reference 1981).

On the

other hand, LVP has a much shorter duration of action, with its
endocrine effects lasting from 6 to 24 hours (Physicians Desk Reference
1981).

Thus, when comparing these two analogues for duration of their

endocrine activity, there is a noticeable difference between them.
One can only wonder at this point whether there is a similar difference
between analogue duration with regard to their behavioral effects.

If

so, the "long-term" effects noted by DeWied and Bohus (1966) may be a
function of the specific analogue used.

In a methodological review

of neuropeptide research involving ACTH and MSH, Beckwith and Sandman
(1978) called attention to a number of variables which may interact
with peptides in behavioral paradigms.

Variables such as dose-

response, time of peptide administration, route of administration,
as well as the specific analogue used, may produce varied results.
These variables still remain to be systematically explored in an
attempt to specify and standardize the specific parameters which
influence the effects obtained in vasopressin research.

Until this

occurs, it is at least necessary to exercise experimental control over
these variables across studies utilizing vasopressin.
Overall, evidence generated from investigations of the effects of
exogenous administration of vasopressin in intact rats has demonstrated
an increased resistance to extinction in animals treated with vasopres
sin (i.e., DeWied & Bohus 1966; DeWied 1976; Ader & DeWied 1972).

16
These results were obtained in both active and passive avoidance
paradigms, and with several different vasopressin analogues.

Unlike

the results discussed from the Brattleboro and hypophysectomy studies,
effects on response acquisition have not been noted with exogenous
vasopressin administration.

It seems therefore, that vasopressin

deficiency may produce different behavioral effects from those
obtained with exogenous vasopressin administration in intact animals.

Actions of Vasopressin as an
Anti-Amnesic Substance
A number of authors citing the protective effects of vasopressin
on amnesia have provided further evidence of a memory effect (consoli
dation and/or retrieval of memory) for vasopressin (Van Wimersma
Greidanus et al. 1975; DeWied & Bohus 1979; Cooper, McNamara, Thompson,
& Marsh 1980).

Puromycin has been shown to block memory of maze

learning in mice for long periods of time when intracerebrally injected
subsequent to training (Flexner, Flexner, & Stellar 1963).

Lande,

Flexner, and Flexner (1972) used a conditioned avoidance task to
examine the effects of DG-LVP on puromycin induced amnesia in mice.
After a retention interval of one to two weeks post-training, those
animals which received DG-LVP prior to training showed a significant
retention of the CAR.

This memory protection was also found in

animals receiving DG-LVP immediately or twelve hours following train
ing, but was not obtained when DG-LVP was administered 24 hours
following training.

Finally, Walter et al. (1975), utilizing the same

paradigm as Lande et al. (1972), examined the protective effects of
LVP and AVP along with a number of other analogues (including DG-LVP
and DDAVP) on the amnesic effects of puromycin on rats.

The results
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obtained indicated that all of these peptides significantly decreased
puromycin induced amnesia.

Thus, these findings provide more support

for the postulation that vasopressin and vasopressin analogues
influence memory consolidation since their actions are time dependent
in relation to the training, and they effectively block or protect
against the amnesic effects of puromycin.
The effect of DG-LVP on CC>2-induced amnesia on a step-through
passive avoidance response was studied by Ritger, Van Riezen, and
DeWied (1974).

Their results suggested that the administration of

DG-LVP reduced the amnesic effects of CC>2 when injected either prior
to the acquisition trial or the test trial.

The authors suggested

that the effects obtained when DG-LVP was administered before acquisi
tion may indicate that this peptide promotes memory consolidation
either through facilitating the consolidation process or by protecting
memory from the amnesic treatment.

They also suggested that

facilitation of retrieval may be involved since DG-LVP had an anti
amnesic effect when injected prior to the test trial.

It appears that

this peptide either promotes memory retrieval processes or blocks/
reverses CC^-induced retrieval disturbances.

Appetitive Motivation
Paradigm Research
Studies discussed thus far have utilized avoidance paradigms to
investigate the behavioral effects of vasopressin, however, vasopressin
has also been found to influence behavior which is appetitively
motivated.

Bohus (1977) investigated the effects of DG-LVP on

sexually motivated behavior in a T-maze.

Rats treated with DG-LVP

made more correct choices during both acquisition and retention, but
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significantly so only during the retention period.

Thus, the mainten

ance of a learned behavior which is seen upon administration of
vasopressin is not only restricted to aversively motivated responses,
but is also apparent when the response is motivated by sexual reward
(appetitive motivation).

Furthermore, it seems from these data that

both acquisition and extinction may be affected by vasopressin
administration.

However, results have not always been consistent in

studies utilizing food-rewarded appetitive paradigms.

Vasopressin was

found to have no effects on the acquisition or extinction of a food
running approach response (Garrud et al. 1974).

But, a subsequent

study reported that vasopressin significantly delayed extinction when
a food-rewarded T-maze task was used (Hostetter et al. 1977).

Conse

quently, when reviewing research from this line of investigation it is
still difficult to draw conclusions about vasopressin's effects upon
appetitively motivated responses.

Few studies have been reported in

this area and more information is needed.

However, it does appear

that effects upon behavior are exerted by vasopressin when appetitively
motivated responses are studied but specific tasks may yield different
results.

Therefore, it seems that this area of research should be

explored further in an attempt to develop our understanding of the
relationship between the response studied and the effects of vasopres
sin upon that response.

Statement of the Problem
The variety of paradigms used to study vasopressin's effects upon
behavior, illustrates that a number of tasks may be affected, under a
number of conditions.

Thus far, the results obtained in studies
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involving vasopressin have been consistent with the hypothesis that
vasopressin exerts effects upon memorial processes (Van Wimersma
Greidanus et al. 1975; DeWied & Gispen 1977; DeWied & Bohus 1979).
Sandman et al. (1972) explored the effects of ACTH/MSH upon memory
using a brightness discrimination task.

The discrimination task

required that the animal avoid shock by running to and displacing one
of two doors (either black or white) in order to enter the goal box.
Subsequently reversal and recall (after 5 days) of the original dis
crimination were studied.

Reversal of the original discrimination was

used as a measure of possible short-term memory (STM) effects, where
facilitated memory would result in impaired reversal performance due
to increased interference from the original discrimination problem
(e.g. memory for the first discrimination would interfere with
acquisition of the reversal discrimination). Recall after the 5-day
retention interval was used as a measure of long-term memory (LTM).
Animals treated with ACTH/MSH demonstrated facilitated reversal as
compared to placebo treated controls.

In addition, no significant

difference was demonstrated between ACTH/MSH and placebo treated
animals on the recall task.

Thus, unlike results which would be

predicted in the case of a memory effect (impaired reversal), Sandman
et al. (1972) found a facilitated reversal, e.g., decreased interfer
ence from original learning in those animals which received peptide
treatment.

These results suggested an attentional effect of ACTH/MSH

on behavior, rather than a memory effect.

Subsequent research

utilizing this discrimination paradigm supported the attentional
proposition (Sandman, Alexander, & Kastin 1973; Beckwith et al. 1976).
This discrimination paradigm is based upon a two-stage attentional
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model of discrimination learning.

According to Mackintosh (1965),

attention and response attachments are both necessary for discrimina
tion learning to occur.

During the reversal learning phase of a

discrimination task, Mackintosh states that " . . .

any procedure that

increases the probability of attending without equally increasing
response strength, will facilitate reversal" (p. 135).

Therefore, if

a procedure is introduced into such a discrimination paradigm which
facilitates attention, reversal learning would be expected to be
facilitated.

If memory for the original discrimination is facilitated,

reversal learning would be expected to be impaired.

This is the major

premise upon which the differentation between memory and attentional
effects is made when utilizing such a discrimination task.
The purpose of this study was to investigate possible memory
and/or attentional effects of vasopressin in an appetitively motivated
brightness discrimination task.

Thus far, such an attentional/

memorial differentation has not been undertaken in animal research on
vasopressin.

The majority of studies exploring vasopressin's possible

behavioral effects have focused upon memory as measured by retention
of an avoidance response.

Thus, because this paradigm makes possible

a separation of attentional and memorial functions, the results will
contribute to our understanding of vasopressin's effects upon behavior
in animals.

Using this particular paradigm will also allow for a

comparison of the obtained results with those obtained from previous
studies involving ACTH/MSH.

Such a comparison could provide further

information regarding the differential effects of these peptides on
behavior.

Furthermore, since few studies have assessed the interaction
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of vasopressin with, appetitive motivation, this study can also
contribute to the literature in this area.
To the author's knowledge, no attempt has been made to investi
gate the possibility of behavioral effects when the vasopressin
analogue, DDAVP, is administered intranasally in animals.

Although

this analogue has been shown to yield the same anti-amnesic effects
as other forms of vasopressin, this route of administration was not
used (Walter et al. 1975).

Since the intranasal route of administra

tion of DDAVP is the one used clinically in humans, investigating
possible behavioral effects with this particular peptide and route
may yield further interesting information.

Also, since this analogue

has become increasingly popular clinically and very little research
has been reported with regard to its possible behavioral effects in
animals, it was thought to be an important analogue variable to
investigate and was therefore chosen for use in this study.
Finally, Beckwith and Sandman (1978) called attention to the
importance of studying light-dark cycles in relation to their effects
when combined with behaviorally active peptides.

Exogenous MSH

administration during a light phase did not affect an animal's perform
ance on a passive avoidance task but when MSH was administered during
a dark phase, passive avoidance responses were significantly inhibited
(Sandman et al. 1971).

Diurnal variation in the effects obtained with

ACTH have also been noted (Pagano and Lovely 1972).

Because rats are

nocturnal animals, with activity levels being highest under dark
conditions, one might expect diurnal variations to be such that
highest hormone (peptide) levels would be obtained in the evening and
lowest levels in the morning.

Recently, Schieving (1979) has documented
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this for corticosterone levels in rats.

Because of relationship and

similarity between the behavioral actions of ACTH/MSH and vasopressin,
the possibility that a diurnal variation might also exist for vaso
pressin levels is likely.

Indeed, a recent study has indicated that

vasopressin does exhibit a rhythmic pattern when measured in cerebral
spinal fluid but not in blood (Reppert, Artman, Swaminathan, & Fisher
1981).

Therefore, a third purpose of this study was to investigate

the possible diurnal influences of vasopressin's actions upon
behavior.
To summarize then, the first purpose of this study was to
investigate the possible effects of vasopressin on an appetitively
motivated brightness discrimination in rats.

Secondly, the efficacy

of utilizing the analogue DDAVP, with an intranasal route of adminis
tration, was explored in this study.
influences were investigated.

Finally, possible diurnal

CHAPTER III

METHOD

Animals
Sixty 70 day old male Holtzman albino rats were used for this
study.

They were housed individually under controlled light-dark

conditions (lights on at 0700 h, off at 1900 h) , receiving indirect
lighting.

The animals were food deprived to 85% of their body weight

and received free access to water while in their home cages.

Apparatus
The test apparatus used was a Thompson-Bryant Discrimination Box
(Thompson & Bryant 1955).

It was constructed from black plexiglas

and consisted of a start box, a choice chamber, and a goal box.

The

floor of the start box and choice chamber consisted of transversely
placed, 4.8 mm bronze rods.
plexiglas.

The floor of the goal box was solid

Two doors, 89 mm square, at the end of the choice chamber,

were the only means of entering the goal box.

The two doors were

separated by a partition which extended 7.5 cm into the choice
chamber.

The choice chamber and the start box were separated by a

guillotine-type door.

The entire apparatus was covered by a three-

sectioned, clear plexiglas lid which prevented the animal's escape.
The apparatus was illuminated by a 100-watt bulb positioned 2 meters
above the center of the choice chamber.
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The discriminative stimuli used were solid white and solid black
doors.

During the pre-training phase, black and white, vertically and

horizontally striped doors were used to shape goal box entry.

Procedure
The animals were randomly assigned to one of six groups:

a

morning experimental (DDAVP) group (N = 10), a morning placebo
(vehicle) group (N = 10), a morning control group (N = 10), an evening
experimental group (N = 10), an evening placebo group (N = 10), and an
evening control group (N = 10).

The morning and evening groups were

handled, treated, and tested in daily sessions separated by a twelve
hour interval.

The experimental animals received 0.06 cc (6 yg) of

DDAVP (desmospressin acetate— Ferring Pharmaceuticals) intranasally
15 minutes prior to testing throughout both the original and reversal
learning tasks.

The placebo groups received 0.06 cc of vehicle

(saline solution, ph adjusted to 4) intranasally 15 minutes prior to
testing throughout the same tasks as the experimental animals.

The

control animals were simply handled and received no intranasal treat
ment solution.

All hormone/placebo treatments were done with the

experimenters blind to the identity of the solution administered.
All animals were fed ad lib for five days and weighed daily in
order to obtain an ad lib feeding weight prior to the pretraining
phase.

The animals ad lib feeding weights ranged from 200 to 300

grams.

Over the next five days, the animals were food deprived and

were gradually decreased to 85% of their ad lib body weight and were
then maintained at this level for the remainder of the experiment.
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Finally, each, animal was handled for 10 minutes each day for 7 days
prior to the pretraining phase of the experiment.

Pretraining
Each animal was permitted to explore the apparatus with free
access to all chambers for 15 minutes on the first day of the pre
training phase.

During this exploration period, ten 45 mg. Noyes food

pellets were placed in the goal box for each animal.
The second day of pretraining consisted of shaping the animals to
enter the goal box by dislodging the doors in the choice chamber.
Initially, vertically and horizontally striped doors were positioned
at the far end of the goal box.

This was done in order to desensitize

the animals to the novel stimuli the doors presented.

When the

animals entered the goal box they were reinforced with one 45 mg. food
pellet.

When the animals began entering the goal box without hesita

tion, the doors were moved into a position so that they partially
obscured the openings in the goal box.

This was done so that each

animal would be trained to dislodge the doors in order to enter the
goal box and obtain reinforcement.

In the final step of pretraining,

the doors were placed into position so that they completely blocked
the entry into the goal box.

This pretraining continued for three

days to a criterion of 5 consecutive errorless entries into the goal
box.

An error was scored if the animal hesitated for 5 seconds in

the choice chamber, returned to the start box before the guillotine
door was completely down, or turned towards the start box after
entering the choice chamber.
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Original Learning
The visual discrimination task during original learning required
the animal to run to the solid white door (positive stimulus),
dislodge it, and enter the goal box.

The solid black door (negative

stimulus) was locked during this phase.

The door positions were

altered according to the Gellerman (1933) series of semi-random
orders.

This is a semi-random series because it contains the

constraint that the positive stimulus never appears on the same side
for more than three consecutive trials.

This is done in order to

counteract any learning of a position preference that might occur in
the animals.

Each animal was given 20 successive trials per day to a

criterion of 9 out of 10 correct responses during one day's testing
session.

An error was scored if the animal approached within 7.5 cm

of the negative stimulus, failed to approach either stimulus within 5
seconds after entering the choice chamber, or turned towards the
start box after entering the choice chamber.

Reversal Learning
Immediately after reaching criterion on the original learning
discrimination task, the positive stimulus was reversed so that the
black door became the positive stimulus.

During this phase, the solid

white door remained locked and the door positions were altered accord
ing to the Gellerman series.

The criterion used for acquisition of

this discrimination was 9 out of 10 correct responses on a single
testing day.

The same judgments were used in scoring errors as were

used during the original learning phase of the experiment.
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Reversal Learning Retention
Upon reaching criterion on the reversal learning discrimination
task, the animals were maintained on deprivation, but received no
exposure to the apparatus for a period of five days.

At the end of

this five day period of retention, the animals were exposed to the
same discrimination problem they received during the reversal learning
phase of the experiment.

During the retention phase, the solid white

door remained locked and the door positions were again altered accord
ing to the Gellerman series.

Thus, this was the same discrimination

task used during the reversal learning phase and their performance was
used as an indication of their reversal learning retention after the
five day rest period.

The criterion used for retention of the

reversal discrimination was 9 out of 10 correct responses on a single
testing day.

The same judgments were used in scoring errors during

this phase as those used for the original and reversal learning
discrimination phases.

CHAPTER IV

RESULTS

Planned comparisons (Hays 1963) were made between the peptide,
the placebo, and the control groups.

As may be seen in Figure 1,

there was a trend towards facilitation of original learning in the
DDAVP treated animals (t = 1.359, df = 38, p = 0.183).

No effects

were found during either reversal learning (t = 0.44, df = 38, p =
0.657) or retention (t = -0.248, df = 38, p = -.805).

These results

suggested a subtle learning effect which was investigated further by
means of forward and backward learning curves plotted for each task
(Hilgard 1951; Hayes 1953; Beckwith et al. 1976).

Inspection of the

learning process during original learning (Figure 2) revealed a
distinct trend towards facilitation of original learning on both
forward and backward learning functions.

The former is evidenced by

the overall superior performance of the group treated with DDAVP after
trial 30 in Figure 2A.

The latter is shown by the superior performance

of the animals treated with DDAVP at the point where the concept was
acquired (note trials 10, 12, and 14 in Figure 2B).

Inspection of the

forward learning curve during reversal learning (Figure 3A) suggested
an initial impairment of reversal in animals receiving DDAVP.

No

differences were noted between groups in the backward learning curve
for reversal learning (Figure 3B).

Inspection of the learning curves
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Learning curves plotted for original learning.

Backward learning
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Forward learning curve

Figure 3.

Learning curves plotted for reversal learning.

B.

Backward learning curve
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for the retention phase (Figure 4) revealed no difference in either of
the functions observed.
Further analysis of the trend towards facilitation of original
learning noted during inspection of the forward and backward learning
curves was undertaken.

This was accomplished by blocking the data

into three intervals based upon the number of trials to criterion
animals took to learn the discrimination (see Table 5).

Although the

differences did not reach satisfactory levels of statistical signifi
cance it is interesting to note that the combined AM/PM data reveal
that twice as many animals treated with DDAVP reached criterion on
original learning within fifty trials as did either placebo or control
animals.
The number of trials to criterion for each learning phase was
further analyzed with a 3 (treatment) X 2 (A.M. - P.M.) X 3 (task)
analysis of variance with repeated measures on the last factor in
order to investigate any possible overall effects (see Tables 6-8).
This analysis revealed a marginally significant effect (F = 3.268,
df = 1 , p = 0.077) for time of testing during reversal learning, with
the morning animals reaching criterion significantly faster than the
evening animals.

There were no other significant effects yielded by

this overall analysis.
Savings scores (Reversal Learning minus Retention divided by
Reversal Learning - multiplied by 100) (Hilgard 1951) were calculated
for each animal as a measure of retention.

The savings score is

expressed as a percentage and is a ratio of the trials saved during
relearning to the trials required originally to learn the reversal
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discrimination.

These savings scores were analyzed with a 3 (treat

ment) X 2 (A.M. - P.M.) analysis of variance.
no significant effects (see Table 9).

This analysis revealed

CHAPTER V

DISCUSSION

The results of this study indicated that there was a distinct
trend towards a facilitation of original learning in those animals
treated with DDAVP.

There was also an initial impairment during

reversal learning in the DDAVP group.

There were no significant

differences between the groups on the reversal learning task or after
the five day retention period.

In addition, there was a marginally

significant effect for time of testing within the reversal learning
task only.

This was a constant effect across groups, with the animals

tested in the morning reaching criterion within fewer trials than
animals tested in the evening.
Since the results obtained in this study were only marginally
significant, several issues pertaining to the specific analogue tested
should be addressed.

First is the issue of DDAVP's effectiveness in

exerting behavioral actions.

DDAVP is an analogue of arginine vasopres

sin (AVP), and the behavioral effects of the latter have been well
documented (DeWied & Bohus 1979; DeWied, Bohus, & Van Wimersma
Greidanus 1975).

To date, such extensive documentation has not taken

place for DDAVP, however data that are available indicate that DDAVP's
effects parallel those obtained with AVP.

When the protective effects

of AVP and DDAVP were compared on the amnesic effects of puromycin in
rats (Walter et al. 1975), results indicated that both are effective
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in significantly decreasing puromycin-induced anmesia.

In addition,

recent evidence has been obtained which indicates DDAVP facilitates
discrimination learning in humans (Beckwith, Petros, Kanaan-Beckwith,
Couk, Haug, & Ryan, manuscript under review).

These results also

suggested that DDAVP directly affected CNS functioning as it did not
appear to influence peripherally mediated responses (i.e., blood
pressure and heart rate).

Thus these studies along with the present

one, provide evidence which suggests that DDAVP is effective in
exerting behavioral actions.

However, conclusive information is still

lacking as to the comparative effectiveness of intranasal and other
routes of administration.

Therefore, valuable information would be

obtained from further investigations comparing various administration
routes with various vasopressin analogues (i.e., DDAVP and AVP).
Vasopressin has the known capacity to induce ACTH release (Gillies
& Lowry 1979).

It has also been demonstrated that ACTH/MSH and vaso

pressin exert similar actions upon extinction behavior in rats (DeWied
& Bohus 1966; DeWied 1969; Bohus et al. 1973; DeWied & Gispen 1977).
Because of this relationship between ACTH/MSH and vasopressin, it is
important to differentiate their effects whenever possible.

These

results indicate that DDAVP clearly did not produce the same effects
on discrimination learning as have been previously obtained from
treatment with ACTH/MSH fragments (Sandman et al. 1972; Sandman et al.
1973; O'Donohue, Handlemann, Loh, Olson, Leibowitz, & Jocobowitz 1981).
ACTH and MSH have been found to facilitate reversal learning of a
visual discrimination task.

Treatment with DDAVP did not result in

such a facilitory pattern, but produced an initial impairment in per
formance on this task.

Treatment with DDAVP did enhance original
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learning of the brightness discrimination as evidenced by superior
performance of the DDAVP group (see Figures 1 and 2).

Treatment with

ACTH/MSH fragments has typically not influenced acquisition of the
brightness discrimination in previous experiments (Sandman et al.
1972; Sandman et al. 1973; however, O'Donohue et al. 1981).

However,

most studies with ACTH/MSH utilized aversive motivation with this
particular task, and when appetitive motivation was used (O'Donohue
et al. 1981) learning of the discrimination was facilitated by MSH
treatment.

Thus, an interaction may exist between the type of moti

vation utilized and the specific behavioral actions exerted by these
peptides.
There is an interesting discrepancy between the effects of ACTH/
MSH peptides and DDAVP which lies in DDAVP's impairment of early
acquisition of the reversal problem.

ACTH/MSH fragments appear to

influence attention according to a two-stage attentional model of
discrimination learning (Mackintosh 1965).

However, the impairment

in reversal learning as a result of treatment with DDAVP suggests that
DDAVP influences memorial rather than attentional processes.

This can

be seen in the subtle perseveration of the originally learned response
in Figure 3A.

This effect is a short-term one however, as the impair

ment is a transitory one and is no longer present when criterion is
reached on the reversal problem (see Figure 3B).

The long-term

effects described by previous authors (DeWied & Bohus 1966; DeWied
1976) were not seen in the retention of the reversal learning problem.
When tested on the reversal learning discrimination after a five-day
retention period, no treatment effects were obtained.

Overall, on

this task, DDAVP appears to influence short-term memorial processes as
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evidenced by the facilitation in acquisition of original learning and
the transitory perseveration of the original discrimination during the
reversal problem.

APPENDICES

APPENDIX A

TABLES OF MEAN TRIALS TO CRITERION
AND MEAN SAVINGS SCORES
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TABLE 1
MEAN TRIALS TO CRITERION FOR ORIGINAL LEARNING

AM

PM

89.9

89.6

Placebo

105.6

114.3

Control

99.2

105.1

DDAVP

GROUP

TABLE 2
MEAN TRIALS TO CRITERION FOR REVERSAL LEARNING

AM

GROUP

PM

DDAVP

212.7

237.2

Placebo

224.1

245.1

Control

202.3

249.1
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TABLE 3
MEAN TRIALS TO CRITERION FOR RETENTION

GROUP

AM

PM

DDAVP

59.6

52.6

Placebo

62.6

42.2

39.6

54.0

Control

\

TABLE 4
MEAN SAVINGS SCORES ON RETENTION

GROUP

AM

PM

DDAVP

79.382

83.053

Placebo

79.979

84.968

Control

86.025

83.427

APPENDIX B

TABLES OF BLOCKED DATA
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TABLE 5
NUMBER OF ANIMALS REACHING CRITERION WITHIN EACH BLOCK OF FIFTY TRIALS

A.

Animals Treated in the Morning

# of Trials to Criterion

0-50

B.

C.

-

51-100

101 plus

DDAVP

4 (NS)a

4 (NS)

2 (NS)

Placebo

2 (NS)

4 (NS)

4 (NS)

Control

2 (NS)

4 (NS)

4 (NS)

0-50

51-100

101 plus

DDAVP

2 (NS)

4 (NS)

4 (NS)

Placebo

0 (NS)

6 (NS)

4 (NS)

Control

1 (NS)

3 (NS)

6 (NS)

0-50

51-100

101 plus

DDAVP

6 (NS)

8 (NS)

6 (NS)

Placebo

2 (NS)

10 (NS)

8 (NS)

Control

3 (NS)

7 (NS)

10 (NS)

Animals Treated in the Evening

Morning and Evening Animals Combined

NS = not significant by means of chi-square test

APPENDIX C

ANALYSIS OF VARIANCE RESULTS
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TABLE 6
ANALYSIS OF VARIANCE OF TRIALS TO CRITERION FOR ORIGINAL LEARNING

Source

Sum of Squares

DF

F

Significance

Group

4150.930

2

0.882

0.420

Times

340.807

1

0.145

over 0.500

Group X Times

212.133

2

0.045

over 0.500

127042.500

54

Unit

TABLE: 7
ANALYSIS OF VARIANCE OF TRIALS TO CRITERION FOR REVERSAL LEARNING

Source

Sum of Squares

DF

F

Significance

Group

1152.639

2

0.133

over 0.500

Times

14198.828

1

3.268

0.077

1958.634

2

0.225

over 0.500

234586.688

54

Group X Times

Unit
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TABLE 8
ANALYSIS OF VARIANCE OF TRIALS TO CRITERION FOR RETENTION

Source

Sum of Squares

DF

F

Significance

Group

876.934

2

0.204

over 0.500

Times

281.666

1

0.131

over 0.500

3080.933

2

0.717

0.493

116003.125

54

Group X Times

Unit

TABLE 9
ANALYSIS OF VARIANCE OF SAVINGS SCORES ON RETENTION

Source

Sum of Squares

DF

F

Significance

Group

108.734

2

0.213

over 0.500

Times

29.475

1

0.116

over 0.500

261.536

2

0.514

over 0.500

13751.227

54

Group X Times

Unit
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